LUNGevity Foundation’s Initiative for Lung Cancer Awareness Month
This November, LUNGevity Foundation is poised to unite communities nationwide in observance of Lung Cancer Awareness Month (LCAM). The foundation aims to raise awareness and foster action by organizing events, educational programs, and advocacy campaigns that highlight the growing need for progress in the fight against lung cancer.
Lung cancer remains the foremost cause of cancer-related deaths in the United States. However, advancements in early detection and treatment have improved outcomes, allowing many patients to live longer, fulfilling lives. Despite this progress, challenges persist, including a late diagnosis for many individuals and the continuing stigma that surrounds the disease. LUNGevity’s mission this November is clear: to inform and empower communities regarding the importance of early detection, access to research funds, and advancements in treatment protocols.
Andrea Ferris, the President and CEO of LUNGevity Foundation, emphasizes the significance of this initiative, stating, "Lung Cancer Awareness Month is a chance to reflect on the strides we've made and to galvanize efforts for what we can still achieve together. We must ensure that the innovations in treatment and detection are accessible to all who need them."
Engaging Nationwide Initiatives
Throughout the month, LUNGevity will present a series of initiatives that call upon the public to learn, engage, and contribute:
- - Every Breath Forward℠ Movement: This nationwide campaign honors individuals impacted by lung cancer and motivates efforts for future advancements. A visual centerpiece will be displayed on the National Mall in Washington, DC, showcasing 60,000 white flags, each representing lives affected by lung cancer. Communities can participate by planting flags at home, making virtual dedications, and sharing in the spirit of remembrance.
- - Breathe Deep TOGETHER Events: On November 7th, special events will take place in Boston, New York City, and Washington, DC, creating opportunities for walks, sharing resources about lung health, education sessions, and for honoring loved ones as well as celebrating survivors. Additionally, through the Breathe Deep Anywhere initiative, participants nationwide can organize their own events to support awareness.
- - Educational Campaigns: LUNGevity aims to debunk misconceptions regarding lung cancer. It is crucial for individuals to know that anyone with lungs can contract this type of cancer. The foundation will disseminate trusted information on risk factors and promote constructive dialogues.
- - Emphasis on Early Detection: During LCAM and heightened efforts on Lung Cancer Screening Day (November 14th), LUNGevity will assist in clarifying screening eligibility and encouraging meaningful discussions about whether screening is pertinent for individuals.
- - Advocacy for Biomarker Testing & Precision Medicine: LUNGevity will highlight the importance of biomarker testing as part of their No One Missed campaign aimed to promote comprehensive biomarker testing. The organization will also acknowledge Cancer Biomarker Awareness Day on November 12, advocating for informed cancer treatments based on these tests.
As part of these efforts, LUNGevity aims to influence policies that bolster research funding, expand support for screening and treatment, and ultimately improve life quality for individuals diagnosed with lung cancer.
The Importance of Community Engagement
LUNGevity’s initiatives highlight the necessity of community involvement. By ensuring that the latest advancements in lung cancer research and care are accelerated effectively across all demographics, they hope to increase awareness and motivate timely conversations regarding screening and supportive care.
The backing from esteemed sponsors, including Boehringer Ingelheim, AstraZeneca, Johnson & Johnson, and several others, furthers LUNGevity’s mission, extending their reach and impact throughout November and beyond.
For more information about how you can get involved in Lung Cancer Awareness Month, visit
LUNGevity.org/LCAM. Together, LUNGevity and the lung cancer community are working towards a future where early detection and effective treatments are the norm, creating a path toward a definitive cure.
Conclusion
With approximately 229,000 new lung cancer diagnoses expected this year, and most cases arising in those without significant tobacco exposure, the imperative for progress is clear. This November, let’s come together in solidarity and hope, advocating for a future where fewer lives are lost to lung cancer than in the past.